More investment needed to counter COVID-19 misinformation, Canada's top doctor says | Canada News Media
Connect with us

News

More investment needed to counter COVID-19 misinformation, Canada’s top doctor says

Published

 on

After a year that saw the highest number of COVID-19 deaths and a massive increase in infections, Canada’s top doctor says more investments are needed to combat misinformation about vaccines and pandemic measures to ensure Canada is ready for possible new variants of concern.

“This is the pandemic that is occurring in (a) full-on social media age, and all of us had to learn how to deal with that as the pandemic evolved. And it’s not easy,” Dr. Theresa Tam said in a year-end interview with Global News.

Misinformation is false or inaccurate information, which can be spread innocuously by those who may not be fully informed of the truth. Disinformation is considered more deliberate and can include malicious content such as hoaxes, phishing and propaganda, according to a definition provided by the United Nations.

Tam called 2022 the “Omicron age,” after the variant arrived in late 2021 and quickly became the dominant variant for the remainder of the year.

Omicron and its hundreds of subvariants have taught the world that SARS-CoV-2 could be much more contagious than previously thought and that the virus is cunningly adept at evading immunity, Tam said.

For example, more than 70 per cent of Canadians have likely been infected with COVID-19 since Omicron arrived, compared to less than five per cent of the population before Omicron, according to blood test studies funded by the federal government through the national COVID-19 Immunity Task Force.

But the virus has also proved it is capable of presenting new surprises and challenges, which is why Tam says it will continue to be a public health concern in 2023.

Communicating this ongoing uncertainty has been a challenge, Tam says, especially when Canadians are “fed up” with the pandemic.

But the rise of mis- and disinformation about COVID-19 vaccines and pushback against public health measures has made that task even more difficult, Tam admitted.

The lessons learned over the last three years of the pandemic have allowed Canada and the world to be better equipped to weather future waves or new variants of the virus, Tam said.

For example, the world now has bivalent vaccines that can prevent severe outcomes, antivirals like Paxlovid to treat symptoms and global surveillance systems to measure increases in cases and mutations of the virus — all of which were not available in 2020.

“We have these tools, and they can be rapidly deployed should we see a significant variant of concern,” Tam said.

“And of course, the personal protective measures and systemic changes like improving ventilation (are) always going to be good in terms of better preparedness for future infections.”

But one of the other lessons learned has been that collective action among populations is key to reducing risk — actions like seeing as many people vaccinated and boosted as possible, Tam said.

And when the advice keeps shifting over time as more information becomes known, it can be challenging, she said.

“I think there is a lot of misunderstanding … (among) people who actually enthusiastically took up the initial vaccine that (now wonder), ‘Why do I need to get boosted, especially if I just had an infection?’” Tam said.

“I just think that collectively we understand that this virus keeps throwing us curveballs.”

That’s why she says more money is needed to counter narratives that could erode the progress Canada and the world have made when it comes to COVID-19.

“I think we need to invest more in countering mis- and disinformation,” Tam said.

“Public health needs to be better at communicating in a way that resonates with people as much as those who may be against the vaccinations (resonate) with people always concerned about safety and effectiveness.  

“That’s the information that people need to know.”

One of the best ways to counter false or misleading narratives is to engage with grassroots leaders and communities that people know and trust, Tam said.

She pointed to the success Canada has seen in decreasing the number of mpox (formerly called monkeypox) cases in the country over the last eight months since that virus first began to spread in Canada in May.

Hundreds of mpox cases were reported at a steadily increasing rate through the spring and summer, until a dedicated public health information campaign was launched tailored to populations who were at the highest risk of infection during the height of the outbreak: men who have sex with men.

This campaign included partnerships with key community stakeholders and vaccine clinics and pop-ups that were accessible and timely for the most at-risk populations.

The rate of new mpox cases has since slowed considerably. No new cases have been reported in Canada in the last three weeks, according to federal data.

This success was only possible through those community partnerships, Tam said.

Similar efforts are needed when it comes to countering misinformation about COVID-19 vaccines, she added.

“This is a very difficult area because people are just fed up with COVID-19, full stop, and yet the virus hasn’t left us and we’ve had to keep updating our vaccine recommendations as well as updating the vaccines themselves, so that’s understandable,” she said.

“But I think we need to provide information in an as accessible way as possible to people to explain why vaccines are needed. But also, I think, engage trusted voices, community leaders, people that different communities trust in order to increase uptake.”

Source link

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version